You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Claims for Patent: 9,737,469


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,737,469
Title:Methods for treating hair loss disorders
Abstract:The invention provides for methods for treating a hair loss disorder in a subject by administering a Janus Kinase/Signal Transducers and Activators of Transcription inhibitor.
Inventor(s):Christiano Angela M., Clynes Raphael
Assignee:The Trustees of Columbia University in the City of New York
Application Number:US15066479
Patent Claims: 2. The method of claim 1 , wherein the hair-loss disorder comprises androgenetic alopecia claim 1 , telogen effluvium claim 1 , alopecia areata claim 1 , telogen effluvium claim 1 , tinea capitis claim 1 , hypotrichosis claim 1 , or hereditary hypotrichosis simplex.3. The method of claim 2 , wherein the alopecia areata is alopecia totalis or alopecia universalis.4. The method of wherein the subject is a human.5. The method of wherein the hair loss-disorder is androgenetic alopecia.6. The method of wherein the hair loss-disorder is alopecia areata.7. A method for inducing hair growth in a subject claim 1 , the method comprising:(a) administering to the subject an effective amount of a Jak1, Jak2, or Jak3 inhibitor, wherein said inhibitor is LY3009104,thereby inducing hair growth in the subject.8. The method of claim 7 , wherein the subject suffers from a hair-loss disorder claim 7 , wherein the hair-loss disorder is selected from—androgenetic alopecia claim 7 , telogen effluvium claim 7 , alopecia areata claim 7 , telogen effluvium claim 7 , tinea capitis claim 7 , hypotrichosis claim 7 , and hereditary hypotrichosis simplex.9. The method of claim 8 , wherein the alopecia areata is alopecia totalis or alopecia universalis.10. The method of wherein the hair loss-disorder is androgenetic alopecia.11. The method of wherein the hair loss-disorder is alopecia areata.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.